Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

In this episode, CANCER BUZZ speaks with Steven Gilmore, PharmD, BCOP, Senior Manager of Clinical Content in Pharmacy and Clinical Programs with McKesson Specialty Health, and Christopher Benton, MD, hematologist and medical oncologist at Rocky Mountain Cancer Centers, to review key considerations and emerging trends for the treatment of anemia in the low-risk MDS population.
In honor of Juneteenth, ACCC President Dr. Nadine J. Barrett and AACI President Dr. Robert A. Winn engaged in an empowering conversation about a shared organizational goal to advance equitable cancer care.
This AI-driven incidental findings program identifies and then monitors pancreatic abnormalities to improve the quality of care to patients who are at increased risk for developing pancreatic cancer.
This machine learning algorithm runs nightly and is linked to a smart texting application that goes out to patients every morning for 7 days following chemotherapy, asking about symptoms like diarrhea, fever, nausea, vomiting, and pain.
Cancer Health Disparities; Challenges and solutions through SDoH assessment and actions • Kashyap Patel, MD, AboiM, BCMAS • Recognized by the US congress as an outstanding citizen who set the Gold Standard for decades • CEO, Carolina Blood and Cancer Care • Imm past President, Community Oncology Alliance • Imm. past Chairman, Clinical Affairs, Association of Community Cancer Centers …
Coherus BioSciences is pleased to announce CMS has granted LOQTORZI® (toripalimab-tpzi) a product-specific J Code J3263 EFFECTIVE JULY 1, 2024* HCPCS Code Description Billable Units NDC J3263 Injection, toripalimab-tpzi, 1 mg 1 mg 70114-0340-01 For additional information: Visit LOQTORZISolutions.com Call 1-844-483-3692 Contact your LOQTORZI Sales Representative or Field …
June 29, 2024
This meeting is presented by the Department of Medicine, Division of Oncology at the Washington University School of Medicine in St. Louis. The course will include multiple presentations developed based on new information presented at the ASCO Annual Meeting. These presentations will be placed in the context of updates in treating and diagnosing malignant diseases, with particular highlights in …
EXECUTIVE OFFICE: 1801 Research Boulevard • Suite 400 • Rockville, MD 20850-3184 • Phone: 301.984.9496 • Fax: 301.770.1949 www.accc-cancer.org OFFICERS President Nadine J. Barrett, PhD, MA, MS, FACCC Wake Forest University School of Medicine and Atrium Health Durham, North Carolina President-Elect Una Hopkins, RN, FNP-BC, DNP, FACCC Montefiore Medical Center Bronx, New …
Please see Important Safety Information for Opdualag throughout and US Full Prescribing Information for Opdualag. RELATIVITY-047: Opdualag™ (nivolumab and relatlimab-rmbw) for the treatment of patients with unresectable or metastatic melanoma1 Opdualag is indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma.1 Please …
In this episode, CANCER BUZZ TV speaks with Tom Lycan, DO, MHS, assistant professor of Hematology & Oncology at the Wake Forest School of Medicine, about a practical tool that can provide a care plan roadmap for providers and patients to mitigate precision medicine disparities.
ACCC joined over 500 organizations nationwide writing in support of the bipartisan Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 2407). ACCC members are all too familiar with the toll cancer takes on patients when diagnosed at a late stage. Early detection and treatment are crucial for improving cancer outcomes and saving lives. ACCC is very happy to learn …
June 27, 2024
Topic: Multiple Myeloma: CAR-T or Bispecifics Join RMOS for an enlightening evening of learning and networking at our June dinner symposium! Indulge in complimentary dining at a renowned sushi restaurant in Denver while witnessing a thought-provoking debate between Dr. Peter Forsberg, Hematologist/ Oncologist at Colorado Blood Cancer Institute, and Dr. Douglas W. Sborov, Director of the Hematology …
The panel at the FDA OCE 4th Annual National Black Family Cancer Awareness Week, Engaging the Generations Conversation on Cancer, forum, explores family and faith in cancer care.
June 27, 2024
Surviving to Thriving: Helping your cancer survivors increase their physical activity through implementation of The Active Living After Cancer Program. Thursday, June 27, 2024 12:00 – 1:00 pm CST Location: Zoom Webinar ID: 889 8265 9982 Passcode: 000619 Scherezade K. Mama, DrPH Assistant Professor Department of Health Disparities Research The University of Texas MD Anderson Cancer Center Karen …
June 26, 2024
You’re invited to participate in the Targeted Oncology™ and Oncology Nursing News® Community Case Forum™ on Wednesday, June 26 at Loews Vanderbilt Hotel in Nashville, Tennessee. HRA® offers compensation of $750 to medical oncologists/hematologists and $500 to advanced practice providers for their consultative insights. After arriving, you’ll spend some time networking with peers while enjoying small …
Many organizations have published formal recommendations, or workup guidelines, for managing irAEs, including ASCO, ESMO, NCCN, and SITC.The following can be used as a directory for the current irAE workup guidelines.
Development of this comprehensive bispecific antibody program included policy development; toxicity management; creation of patient and staff education documents; creation of clinician tools like a toxicity scoring and charting tool and an electronic order set that segregates treatment options; and a monitoring system to safely transition patients from inpatient to outpatient care.
Explore key takeaways from the California Health Care Foundation discussion on artificial intelligence and its effect on health care delivery in California.
This rule-based informatics solution pulls from the electronic health record to automate the election of an appropriate biosimilar therapy based on the patient’s insurance and hospital formulary preferences, streamlining prior authorization and approval processes. This e-tool decreased administrative burden to providers, pharmacists, and prior authorization specialists and increased biosimilar utilization …